Background: The aim of the present study was to evaluate serum nitric oxide (NO) PTSD (r=0.118; p=0.727 
INTRODUCTION
Posttraumatic stress disorder (PTSD) is a mental disorder that compromises balance in organism by affecting fundamental spheres of human functioning: psychological, physiological and social-interpersonal. PTSD has been long treated as exclusively psychiatric disorder. Recently numerous studies tried to establish role of complex neuroendocrine, immunological and inflammatory processes on molecular level, which are involved in PTSD development with consequences on whole organism (Yehuda 2002 , Wong 2002 , Altemus et al. 2006 ). Special emphasis is given to discovery of signal molecules, mediators and transmitters that are likely involved in PTSD pathogenesis, and their interrelations with the purpose of unraveling mechanism of PTSD development.
Nitric oxide (NO) is free radical gaseous molecule, easily dissolvable in lipids, which is present in all cells of human body. NO is synthesized enzymatically from amino acid L-arginine by three distinct isoforms of the enzyme, nitric oxide synthase (NOS). Two of these isoform are expressed in constitutive manner, predominantly in the vascular endothelium (eNOS) and in the nervous system (nNOS). Under normal physiological condition these isoforms of NOS generate low, transient levels of NO in response to increases in calcium concentrations. These low levels of NO contribute to blood pressure regulation, platelet aggregation and adhesion, gastrointestinal motility and neurotransmission (Bredt 1999 , Roberts et al. 2008 , Guix et al. 2005 ). However, third isoform inducible NOS (iNOS) has special role. When it is induced by endotoxine and/or cytokines, it generates high sustained levels of NO. In certain conditions, NO would produce peroxynitrite contributing to cell cytotoxicity and tissue damage and up-regulation of the inflammatory response. In fact an excess of NO is involved in pathophysiology of numerous diseases, including cardiovascular and metabolic diseases (Omar et al. 2016) , kidney disease (Orida & Lai 2000) , inflammatory bowel disease (Avdagi et al. 2013 ), neurological diseases (Ibragic et al. 2012 ), many tumors (Vannini et al. 2015) etc.
Studies have shown pivotal role of NO in physiological pathways of neurotransmission, immunological defense and homeostasis. It has been postulated that excess in NO production may have important role in development of cerebral ischemia, Alzheimer's disease, epilepsy and multiple sclerosis (Lucas et al. 2006 ). Decrease in NO production has been related to hypertension, angina pectoris and impotency (Moncada et al. 1991) . Studies so far have been able to elucidate roles of NO in different physiological and pathopysiological conditions. However, data regarding importance of NO in PTSD pathogenesis are scarce and insufficient.
C-reactive protein (CRP) is sensitive systemic marker of inflammation, infection, and tissue damage. In vivo and in vitro studies have reported that CRP itself has pro-inflammatory and anti-inflammatory characteristics. Pro-inflammatory features of CRP are reflected in its ability to activate complement system, induce proinflammatory cytokines, and in inhibition of eNOS synthesis (Zaciragic et al. 2013 ). Anti-inflammatory features of CRP are less known. They are mainly reflected in its ability to increase release of anti-inflammatory cytokines such as IL-10, as well as, in its ability to stimulate expression of receptor IL-1 antagonists and in its ability to inhibit release of INF-(McDade 2012). The role of inflammation in the pathogenesis of PTSD is far from being fully understood and studies that evaluated concentration of CRP in PTSD patients have given inconclusive and discordant results (Spitzer et al. 2010 , Von Känel et al. 2007 ).
The aim of this study was to evaluate serum NO and CRP concentration in veterans with and without PTSD and compare them with values in the control group of healthy subjects. Furthermore, we aimed to assess whether there is a correlation between serum NO and CRP concentrations in tested groups. The hypothesis of the present study was that serum NO and CRP concentrations are different and that there is a correlation between NO and CRP in tested groups.
SUBJECTS AND METHODS

Subjects
Cross-sectional study, conducted at Clinic for Psychiatry Clinical Center University of Sarajevo (CCUS), included 90 Bosnian male individuals with and without experience of direct war combat. Subjects were divided into three groups: Experimental group 1-included 30 veterans of male gender with experience of direct war combat, average age of 48.60±6.32 years, with symptoms that qualify for PTSD diagnosis. Experimental Group 2 -included 30 veterans of male gender with experience of direct war combat, average age of 49.70±4.72 years, without symptoms that qualify for PTSD diagnosis. Control group of subjects consisted of 30 apparently healthy volunteers, average age of 49.66±6.32 years, without experience of direct war combat and without symptoms that qualify for PTSD diagnosis.
The participants from the PTSD group were recruited as a consecutive sample from the pool of patients who received out-patient treatment for PTSD in the Unit for Trauma-related Disorders at the Department of Psychiatry of the University Clinical Center Sarajevo. Participants from the non-PTSD and control group were recruited from the community, using the snowball method (Bloor et al. 1991) .
In order to increase the validity of the results, we have defined the inclusion and exclusion criteria in a way that would enable better homogenization of groups of participants in most factors affecting the serum concentration of CRP and NO. Inclusion criteria were that all participants were male, aged between 40 and 60, non-smokers, non-alcohol drinkers and did not take any prescription or non-prescription drugs that affected serum levels of CRP and NO or suffered from any somatic condition that affected these levels (acute and chronic inflammatory conditions, cancers, diabetes mellitus, hyperthyroidism, hypothyroidism, psoriasis, cerebrovascular insult, vascular dementia).
Detailed history was taken from all individuals included in the study, and objective physical and neuropsychiatric examination was done by trained specialist. Subjects from all three groups were tested for presence of PTSD according to the guidelines in the 10 th revision of the International Classification of Diseases (ICD-10) (WHO 2011). This study was conducted in according with the Helsinki Declaration and was approved by the Local Ethics Committee. With the informed consent of the subjects in the survey, we respect the patient's right to privacy, and the patient's confidential information is not compromised.
Biochemical analysis
For biochemical analysis all blood samples were collected in morning hours from the cubital vein using vacutainer technique. Serum CRP was determined by particle-enhanced immunonephelometry with the use of BN II analyzer at Department of Clinical Chemistry and Biochemistry Clinical Center University of Sarajevo. CardioPhase high-sensitivity CRP (DADE BEHRING, Marburg, Germany) was used a diagnostic reagent. CardioPhasehs-CRP consists of a suspension of polystyrene particles coated with mouse monoclonal antibodies to CRP. Reference interval for CRP with the use of this method is from 0 to 5 mg/L, and the lower limit of CRP detection is 0.18 mg/L. Serum NO concentration was determined at the Department of Human Physiology, Medical Faculty University of Sarajevo. Blood samples were allowed to coagulate. After coagulation the samples were centrifuged at 2000g for 5 min, and the serum samples were deproteinized by adding 750 µl of distilled water and 50 µl of 30% ZnSO4 to 250 µl of each serum sample. Samples were further centrifuged at 2000g for 10 min and frozen at -200°C until the analysis was performed.
The serum NO concentration was determined by measuring nitrite concentration, a stable metabolic product of NO with oxygen. Conversion of nitrates (NO3-) to nitrites (NO2-) was done with elementary zinc. The nitrite concentration was determined by classic colorimetrical Griess reaction (Green et al. 1982) . Absorbance was measured at 546 nm. The results were expressed as µmol/L.
Statistical analysis
The Shapiro-Wilk test of normality was used to test the normality and variance homogeneity of data. Data are presented as mean ± standard error of the mean (SEM). Differences in normally distributed variables between groups were tested by ANOVA test. Coefficient of correlation was assessed by Pearson's test. A p value of less then 0.05 was considered statistically significant. The software used was SPSS for Windows (version 12.0; SPSS, Chicago, IL, USA).
RESULTS
Serum NO concentration in veterans without PTSD was lower (7.12±2.60 µmol/L) then serum NO concentration in veterans with PTSD (7.64±4.43 µmol/L), but observed difference was not statistically significant. Serum NO concentration in the control group (11.26±7.01µmol/L) was statistically significantly higher (p<0.05) compared to serum NO concentration in veterans with and without PTSD (Figure 1 ).
Results are presented as mean ± SEM *-compared to control group; **-compared to veterans without PTSD p -probability; NS -not significant Results are presented as mean ± SEM *-compared to control group; **-compared to veterans without PTSD p -probability; NS -not significant Our findings are not in accordance with data from animal models which have shown that production of NO by iNOS is increased during prolonged stress since our results have shown decreased levels of NO in veterans with and without chronic PTSD compared to control subjects without direct experience of war combat and without symptoms of PTSD. Contrary to our observation, experimental findings have demonstrated that iNOS produces in brain cells NO in a sustainable manner leading to increased levels of NO that results in local damage of neurons and in shrinking of hypocampus which is often seen in patients with PTSD (Harvey et al. 2003 ).
Results of our study have shown increased values of CRP in veterans with and without PTSD compared to control subjects. Veterans with PTSD had higher concentration of serum CRP compared to veterans without PTSD but difference was not statistically significant. Results obtained in our study are in accordance with results by Spitzer et al. (2010) who have reported that PTSD positive subjects had higher chances of having increased levels of CRP compared to subjects without PTSP. Authors suggested that there is a close relation between PTSD and chronic low-grade inflammation which may represent one of the psychobiological pathways from PTSD to poorer physical health and development of different diseases. Accordingly, Vaccarino et al. (2010) reported that twins with PTSD had 69% higher values of serum CRP compared to theirs twin brother without PTSD. Contrary to above findings are results by Von Känel et al. (2007) who reported increased values of TNF-alpha (TNF-) and IL-1beta (IL-1 ) in patients with PTSD, whereas no difference in serum CRP was observed between PTSD patients and control group.
Association between serum levels of NO and CRP in patients with and without PTSD has not been investigated extensively so far. Results of our study have determined no correlation between serum concentration of NO and CRP in the control group and in veterans with PTSD. However, statistically significant negative correlation between serum NO and CRP levels was observed in veterans without PTSD. Since by searching the literature we could not find similar study we could not compare our results with results of other authors. Possible explanation for obtained results might be proven effect of CRP on inhibition of eNOS in experimental studies (Singh et al. 2007 , Hein et al. 2009 ). Results of these studies have shown that CRP inhibits GTP cyclohydrolase 1 and stimulates NADPH oxidase which induces decrease of tetrahydrobiopterin and increase of reactive oxygen species resulting in decreased activity of eNOS and consequently decreased bioavailability of NO. Possible explanation for unobserved correlation between CRP and NO in veterans with PTSD might be that studies thus far have shown that CRP affects different isoform of NOS in a different manner. Namely, CRP negatively influences production of eNOS, and on the other hand, CRP has shown positive influence on iNOS especially in conditions of chronic stress (Oosthuizen et al. 2005) . It remains to be elucidated whether there is an imbalance between these two NOS isoforms and over stimulation of one isoform over another that contributes to insignificant correlation between CRP and NO in veterans with PTSD observed in the present study. Better understanding of potential association between serum NO and CRP is warranted is patients with PTSD.
In interpreting the findings of the current study, several limitations should be acknowledged. Firstly, the sample size was small consisting of veterans with and without PTSD and control group from select population and, therefore, the results cannot be generalized over the whole population. Secondly, the cross-sectional design of the study prevents us from deducing any causal relations between our findings. Thirdly, the study group consisted of patients of just one Unit for Trauma-related Disorders. However, the subjects included in the study come from different regions of the country.
Results of the present study suggest possible involvement of chronic inflammation and endothelial dysfunction in the pathogenesis of PTSD. Further large prospective population-based studies and mechanistic studies are still needed to validate our findings. Clinical relevance and importance of obtained results remain to be elucidated.
CONCLUSION
The present study has showed significant increase of serum CRP and significant decrease of serum NO concentrations in veterans with and without PTSD compared to control subjects. Furthermore, statistically significant negative correlation between serum NO and CRP concentration in veterans without PTSD was determined, where as such correlation was not observed in control subjects and veterans with PSTD. Obtained results point to complex mechanisms in PTSD pathogenesis that require further exploration.
